By Devika Patel
Knoxville, Tenn., Jan. 23 - Bond Laboratories, Inc. completed a $1.25 million private placement of 10% cumulative perpetual series B preferred stock on Dec. 31, according to an 8-K filed Friday with the Securities and Exchange Commission.
The company sold 125 preferreds at $10,000 apiece to Vicis Capital Master Fund.
Vicis also received 7.5 million common shares.
Bond Laboratories, based in Solana Beach, Calif., is a marketer of healthy food and beverage products.
| Issuer: | Bond Laboratories, Inc.
|
| Issue: | Cumulative perpetual series B preferred stock, 7.5 million common shares
|
| Amount: | $1.25 million
|
| Shares: | 125
|
| Price: | $10,000
|
| Dividends: | 10%
|
| Warrants: | No
|
| Investor: | Vicis Capital Master Fund
|
| Settlement date: | Dec. 31
|
| Stock symbol: | Nasdaq: BNLB
|
| Stock price: | $0.15 at close Dec. 31
|
| Market capitalization: | $6.05 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
